Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical use of 1-alpha-hydroxyvitamin D3.

× No keyword cloud information.

12 in total

1. Long-term therapy with 1alpha-hydroxyvitamin D3 in children with 'pseudo-deficiency' rickets.

Authors: S Balsan; M Garabedian; V Courtecuisse; J Guéris; J P Dommergues; L Creignou; M J le Denuff; J Rivron
Journal: Clin Endocrinol (Oxf) Date: 1977-12 Impact factor: 3.478

2. Familial forms of vitamin D-resistant rickets revisited. X-linked hypophosphatemia and autosomal recessive vitamin D dependency.

Authors: D Fraser; C R Scriver
Journal: Am J Clin Nutr Date: 1976-11 Impact factor: 7.045

Review 3. Basic and clinical concepts related to vitamin D metabolism and action (first of two parts).

Authors: M R Haussler; T A McCain
Journal: N Engl J Med Date: 1977-11-03 Impact factor: 91.245

Review 4. Physiological and therapeutic differences between vitamin D, its metabolites and analogues.

Authors: J A Kanis; R G Russell; R Smith
Journal: Clin Endocrinol (Oxf) Date: 1977-12 Impact factor: 3.478

5. Bone disease and hyperparathyroidism in chronic renal failure: the effect of 1alpha-hydroxyvitamin D3.

Authors: M Peacock; J E Aaron; G S Walker; A M Davison
Journal: Clin Endocrinol (Oxf) Date: 1977-12 Impact factor: 3.478

6. Effects of 1alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 on calcium and phosphorus metabolism in hypoparathyroidism.

Authors: R M Neer; M F Holick; H F DeLuca; J T Potts
Journal: Metabolism Date: 1975-12 Impact factor: 8.694

Clinical use of 1-alpha-hydroxyvitamin D3.

1. Long-term therapy with 1alpha-hydroxyvitamin D3 in children with 'pseudo-deficiency' rickets.

2. Familial forms of vitamin D-resistant rickets revisited. X-linked hypophosphatemia and autosomal recessive vitamin D dependency.

Review 3. Basic and clinical concepts related to vitamin D metabolism and action (first of two parts).

Review 4. Physiological and therapeutic differences between vitamin D, its metabolites and analogues.

5. Bone disease and hyperparathyroidism in chronic renal failure: the effect of 1alpha-hydroxyvitamin D3.

6. Effects of 1alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 on calcium and phosphorus metabolism in hypoparathyroidism.

7. Variable response to long-term 1alpha-hydroxycholecalciferol in haemodialysis osteodystrophy.

8. Rate of reversal of hypercalcaemia and hypercalciuria induced by vitamin D and its 1alpha-hydroxylated derivatives.

9. The effect of 1alpha-hydroxyvitamin D3 with and without oestrogens on calcium balance in post-menopausal women.

Review 10. Metabolism and action of the hormone vitamin D. Its relation to diseases of calcium homeostasis.